The Critical Importance of Molecular Biomarkers and Imaging in the Study of Electrohypersensitivity. A Scientific Consensus International Report
Abstract
Overview
Clinical research is vital for establishing objective diagnostic criteria and treatments through observations and various biological and radiological findings.
Findings
The report underscores the limitations of current testing methods for Electrohypersensitivity (EHS), specifically the provocation tests, which fail to ascertain the causative origins of EHS symptoms. These tests are scrutinized for depending heavily on multiple EMF-associated physical and biological parameters without having in place defined objective criteria for EHS.
- Emphasizes the non-negligible role of electromagnetic field (EMF) exposure as a symptomatic trigger in EHS patients despite test outcomes suggesting otherwise.
- Argues against the characterization of EHS symptoms as solely psychosomatic or nocebo effects.
Conclusion
The report advocates for recognizing EHS as a distinct neuropathological disorder and recommends including it in the WHO International Classification of Diseases.